The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Seasonal Influenza Vaccines Therapeutics-Global Market Insights and Sales Trends 2025

Seasonal Influenza Vaccines Therapeutics-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1814826

No of Pages : 104

Synopsis
Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.
The global Seasonal Influenza Vaccines Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Seasonal Influenza Vaccines Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Seasonal Influenza Vaccines Therapeutics market. Paediatrics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adolescence segment is estimated at % CAGR for the next seven-year period.
The market for seasonal influenza vaccines is driven by the demand for preventive healthcare measures and the need to reduce the burden of seasonal flu on healthcare systems. The market's growth is also influenced by the growing emphasis on vaccination and immunization programs globally.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Seasonal Influenza Vaccines Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Seasonal Influenza Vaccines Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Seasonal Influenza Vaccines Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Seasonal Influenza Vaccines Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Seasonal Influenza Vaccines Therapeutics covered in this report include GSK, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Hualan Biological Engineering, Sinovac Biotech and Changchun Institute of Biological Products Co., Ltd., etc.
The global Seasonal Influenza Vaccines Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Hualan Biological Engineering
Sinovac Biotech
Changchun Institute of Biological Products Co., Ltd.
Shanghai Institute of Biological Products Co., Ltd.
Global Seasonal Influenza Vaccines Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Seasonal Influenza Vaccines Therapeutics market, Segment by Type:
Paediatrics
Adolescence
Adults
Elderly
Global Seasonal Influenza Vaccines Therapeutics market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Seasonal Influenza Vaccines Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Seasonal Influenza Vaccines Therapeutics
1.1 Seasonal Influenza Vaccines Therapeutics Market Overview
1.1.1 Seasonal Influenza Vaccines Therapeutics Product Scope
1.1.2 Seasonal Influenza Vaccines Therapeutics Market Status and Outlook
1.2 Global Seasonal Influenza Vaccines Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2029)
1.4 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
2 Seasonal Influenza Vaccines Therapeutics Market by Type
2.1 Introduction
2.1.1 Paediatrics
2.1.2 Adolescence
2.1.3 Adults
2.1.4 Elderly
2.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
3 Seasonal Influenza Vaccines Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
4 Seasonal Influenza Vaccines Therapeutics Competition Analysis by Players
4.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2022)
4.3 Date of Key Players Enter into Seasonal Influenza Vaccines Therapeutics Market
4.4 Global Top Players Seasonal Influenza Vaccines Therapeutics Headquarters and Area Served
4.5 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Seasonal Influenza Vaccines Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.1.4 GSK Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.2.4 Novartis Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 CSL
5.3.1 CSL Profile
5.3.2 CSL Main Business
5.3.3 CSL Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.3.4 CSL Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 MedImmune Recent Developments
5.4 MedImmune
5.4.1 MedImmune Profile
5.4.2 MedImmune Main Business
5.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.4.4 MedImmune Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 MedImmune Recent Developments
5.5 Sanofi-Pasteur
5.5.1 Sanofi-Pasteur Profile
5.5.2 Sanofi-Pasteur Main Business
5.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.5.4 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi-Pasteur Recent Developments
5.6 Solvay
5.6.1 Solvay Profile
5.6.2 Solvay Main Business
5.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.6.4 Solvay Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Solvay Recent Developments
5.7 Hualan Biological Engineering
5.7.1 Hualan Biological Engineering Profile
5.7.2 Hualan Biological Engineering Main Business
5.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.7.4 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Hualan Biological Engineering Recent Developments
5.8 Sinovac Biotech
5.8.1 Sinovac Biotech Profile
5.8.2 Sinovac Biotech Main Business
5.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.8.4 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Sinovac Biotech Recent Developments
5.9 Changchun Institute of Biological Products Co., Ltd.
5.9.1 Changchun Institute of Biological Products Co., Ltd. Profile
5.9.2 Changchun Institute of Biological Products Co., Ltd. Main Business
5.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.9.4 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Developments
5.10 Shanghai Institute of Biological Products Co., Ltd.
5.10.1 Shanghai Institute of Biological Products Co., Ltd. Profile
5.10.2 Shanghai Institute of Biological Products Co., Ltd. Main Business
5.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.10.4 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Developments
6 North America
6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Seasonal Influenza Vaccines Therapeutics Market Dynamics
11.1 Seasonal Influenza Vaccines Therapeutics Industry Trends
11.2 Seasonal Influenza Vaccines Therapeutics Market Drivers
11.3 Seasonal Influenza Vaccines Therapeutics Market Challenges
11.4 Seasonal Influenza Vaccines Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’